Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
In reply to the discussion: A new Gallup poll found that Americans now have the lowest-ever views of the U.S. health system [View all]Celerity
(55,457 posts)60. at least 4 centrist Democrats tried to scupper Biden's pharma cost reductions
Democrats Josh Gottheimer (NJ), Wiley Nickel (NC), Scott Peters (CA), and Donald Davis (NC) are all co-sponsored at least one of multiple bills that would stifle regulators ability to bring down prices of drugs covered by the Medicare. The bills would significantly reduce or outright block the drug price reduction framework contained in Biden's 2022 Inflation Reduction Act.
3 of the 4 are No Labels' Problem Solvers Caucus members, with Gottheimer being the co-chair, and the 4th, Davis, was the lone Democratic co-sponsor of a bill by Rethugs Greg Murphy and Brett Guthrie that significantly weakens Medicare's ability to lower prices:
All 4 are in the moderate/centrist New Democrat Coalition, and Nickel and Gottheimer are also in the conservative Blue Dog Coalition.
The lone Democrat willing to weaken Medicares power to negotiate drug prices
https://www.statnews.com/2024/02/05/democrat-weaken-medicare-drug-price-negotiation/
https://www.statnews.com/2024/02/05/democrat-weaken-medicare-drug-price-negotiation/
All 4 are in the moderate/centrist New Democrat Coalition, and Nickel and Gottheimer are also in the conservative Blue Dog Coalition.
One of the bills, the Optimizing Research Progress Hope and News (ORPHAN) Cures Act, would exclude vital drugs for many diseases from the price reduction process.
https://www.congress.gov/bill/118th-congress/house-bill/5539/text?s=1&r=88
https://www.congress.gov/bill/118th-congress/house-bill/5539/text?s=1&r=88
Two other bills,
the Maintaining Investments in New Innovation (MINI) Act
https://www.congress.gov/bill/118th-congress/house-bill/5547
and the Ensuring Pathways to Innovative Cures (EPIC) Act,
https://www.congress.gov/bill/118th-congress/house-bill/7174/cosponsors?s=7&r=1
would delay or block the price reduction apparatus for many other drugs.
the Maintaining Investments in New Innovation (MINI) Act
https://www.congress.gov/bill/118th-congress/house-bill/5547
and the Ensuring Pathways to Innovative Cures (EPIC) Act,
https://www.congress.gov/bill/118th-congress/house-bill/7174/cosponsors?s=7&r=1
would delay or block the price reduction apparatus for many other drugs.
The four have cumulatively taken in more than $400,000 from Big Pharma during just the 20232024 congressional session.
https://www.opensecrets.org/members-of-congress/don-davis/industries?cid=N00049636&cycle=2024
https://www.opensecrets.org/members-of-congress/josh-gottheimer/industries?cid=N00036944&cycle=2024
https://www.opensecrets.org/members-of-congress/wiley-nickel/pacs?cid=N00049133&cycle=2024
https://www.opensecrets.org/members-of-congress/scott-peters/industries?cid=N00033591&cycle=2024
https://www.opensecrets.org/members-of-congress/don-davis/industries?cid=N00049636&cycle=2024
https://www.opensecrets.org/members-of-congress/josh-gottheimer/industries?cid=N00036944&cycle=2024
https://www.opensecrets.org/members-of-congress/wiley-nickel/pacs?cid=N00049133&cycle=2024
https://www.opensecrets.org/members-of-congress/scott-peters/industries?cid=N00033591&cycle=2024
Edit history
Please sign in to view edit histories.
62 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
RecommendedHighlight replies with 5 or more recommendations
A new Gallup poll found that Americans now have the lowest-ever views of the U.S. health system [View all]
Passages
Dec 2024
OP
The solution is bodyguards and motorcades for health insurance execs - and snipers on rooftops
dalton99a
Dec 2024
#2
The good news is it still functions well at high levels of expertise 27% of the time
bucolic_frolic
Dec 2024
#3
The problem isn't health *care* - it's generally good *if you can get it and pay for it.*
Ocelot II
Dec 2024
#11
yep, I'm hearing the same people who were against the public option are the ones who have no sympathy for CEO murder.
uponit7771
Dec 2024
#10
Access issues are also better dealt-with in most countries that have a national system.
Aristus
Dec 2024
#47
The same people who voted against the Public Option are the same people who rate PHI low
uponit7771
Dec 2024
#9
Yep, read an OP that the M$M is just now teaching about tariffs !!! People I know who are fairly educated don't ...
uponit7771
Dec 2024
#15
"Dems need to be out front on this stat." 👈🏾👈🏾👈🏾 THIS !!!! I think I wrote and OP on this that if dems have ....
uponit7771
Dec 2024
#21
When the system is run largely by insurers whose policy is to deny claims from "insured" people who depend on them
DFW
Dec 2024
#24
Democrats running for Congress in 2026 need to be focusing on this issue now.
Lonestarblue
Dec 2024
#27
The big question is are Americans willing to demand a different system and will Congress react. In earlier Gallup poll,
Silent Type
Dec 2024
#29
The richest nation in the world and we have squat for a health system.
republianmushroom
Dec 2024
#45